Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

• The company highlights its approach to integrating real-time data analytics with automated PCR infrastructure
• The standalone booth features STAgora simulation and an interactive touchscreen experience
• An enhanced CURECA model is presented, illustrating next-generation automated laboratory workflows
• Strong on-site engagement from global healthcare and laboratory professionals, researchers, and industry stakeholders

SEOUL, South Korea, April 20, 2026 /PRNewswire/ -- Seegene, a global molecular diagnostics company, announced that it introduced STAgora, a real-time data analytics platform based on aggregated statistical testing data, and presented an enhanced model of its automated PCR workflow concept CURECA at ESCMID Global 2026 (formerly ECCMID), held April 17–21 in Munich, Germany, drawing interest from healthcare professionals attending the event.

Throughout the exhibition, Seegene's booth drew strong on-site interest from healthcare professionals, laboratory specialists, academic researchers, and industry stakeholders worldwide. Visitors explored the automated PCR workflow at the CURECA station and engaged in discussions about its potential applications. At the STAgora station, attendees experienced live simulations of the platform, demonstrating strong interest in its intuitive interface and aggregated data visualization capabilities.

At the conference, Seegene presented its key message, "From Numbers to Insights", highlighting how automated testing infrastructure and real-time data analytics can work together to support a better understanding of population-level and public health-related trends.

"STAgora is designed to connect PCR testing data generated around the world in real time and provide a clearer view of infectious disease trends based on aggregated statistics," said Young Seag Baeg, New Business Officer at Seegene. "We are continuing to explore how real-time data analytics, combined with automated testing infrastructure, can help laboratories better understand infection patterns and expand the practical use of aggregated testing data."

At the booth, visitors explored real-time dashboards presenting comparative data between single-target and syndromic PCR testing outputs, regional infection trends over time, pathogen-specific positivity rates and co-infection patterns. The ability to analyze aggregated test results alongside regional epidemiological data drew particular attention from attendees.